Tcf19-KO 基因敲除小鼠

1. Ma, Xinyue, Wang, Qiuman, Sun, Chenggong, Zhang, Qing, Kong, Beihua. 2023. Targeting TCF19 sensitizes MSI endometrial cancer to anti-PD-1 therapy by alleviating CD8+ T cell exhaustion via TRIM14-IFN-β axis. In Cell reports, 42, 112944. doi:10.1016/j.celrep.2023.112944. https://pubmed.ncbi.nlm.nih.gov/37566545/

2. Li, Shu-Yu, Zhang, Nan, Zhang, Hao, Huang, Chen-Shen, Li, Xing-Rui. 2024. Deciphering the TCF19/miR-199a-5p/SP1/LOXL2 pathway: Implications for breast cancer metastasis and epithelial-mesenchymal transition. In Cancer letters, 597, 216995. doi:10.1016/j.canlet.2024.216995. https://pubmed.ncbi.nlm.nih.gov/38851313/

3. Tian, Yahui, Xin, Shaowei, Wan, Zitong, Xiong, Yanlu, Han, Yong. 2024. TCF19 promotes cell proliferation and tumor formation in lung cancer by activating the Raf/MEK/ERK signaling pathway. In Translational oncology, 45, 101978. doi:10.1016/j.tranon.2024.101978. https://pubmed.ncbi.nlm.nih.gov/38701650/

4. Mondal, Payel, Sen, Sabyasachi, Klein, Brianna J, Roy, Siddhartha, Das, Chandrima. 2019. TCF19 Promotes Cell Proliferation through Binding to the Histone H3K4me3 Mark. In Biochemistry, 59, 389-399. doi:10.1021/acs.biochem.9b00771. https://pubmed.ncbi.nlm.nih.gov/31746185/

5. Zhou, Zi-Hao, Chen, Gang, Deng, Cheng, Qiao, Gui-Bin, Ben, Xiao-Song. 2019. TCF19 contributes to cell proliferation of non-small cell lung cancer by inhibiting FOXO1. In Cell biology international, 43, 1416-1424. doi:10.1002/cbin.11189. https://pubmed.ncbi.nlm.nih.gov/31141247/

6. Yang, Grace H, Fontaine, Danielle A, Lodh, Sukanya, Roopra, Avtar, Davis, Dawn Belt. 2021. TCF19 Impacts a Network of Inflammatory and DNA Damage Response Genes in the Pancreatic β-Cell. In Metabolites, 11, . doi:10.3390/metabo11080513. https://pubmed.ncbi.nlm.nih.gov/34436454/

7. Zeng, C Xian, Fu, S Bin, Feng, W Sen, Li, F Xiao, Gao, P. 2018. TCF19 enhances cell proliferation in hepatocellular carcinoma by activating the ATK/FOXO1 signaling pathway. In Neoplasma, 66, 46-53. doi:10.4149/neo_2018_171227N845. https://pubmed.ncbi.nlm.nih.gov/30509085/

8. Mondal, Payel, Gadad, Shrikanth S, Adhikari, Swagata, Prasad, Parash, Das, Chandrima. . TCF19 and p53 regulate transcription of TIGAR and SCO2 in HCC for mitochondrial energy metabolism and stress adaptation. In FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 35, e21814. doi:10.1096/fj.202002486RR. https://pubmed.ncbi.nlm.nih.gov/34369624/

9. Du, W-B, Huang, Z, Luo, L, Zhang, W-B, Meng, Y. . TCF19 aggravates the malignant progression of colorectal cancer by negatively regulating WWC1. In European review for medical and pharmacological sciences, 24, 655-663. doi:10.26355/eurrev_202001_20042. https://pubmed.ncbi.nlm.nih.gov/32016966/

10. Tan, Jing, Lian, Haiping, Zheng, Qi, Yang, Tingting, Wang, Tuo. 2025. TCF19 Enhances Glioma Cell Proliferation via Modulating the Β-Catenin Signaling Pathway through Accelerating DHX32 Transcription. In Current cancer drug targets, , . doi:10.2174/0115680096360071241215171342. https://pubmed.ncbi.nlm.nih.gov/39838676/